Herpes simplex virus establishes latent infections in the nuclei of sensory neurons. These infections are characterized by the abundant expression of a series of 5 coterminal transcripts termed the latency-associated transcripts (LATs). Available evidence indicates that LAT expression is specifically regulated in latently infected neurons. Although previous studies have examined the regulation of LAT expression in neuronal and nonneuronal cells, the mechanism of regulation of LAT expression in neuronal cells in response to external factors has not been investigated. To address this question, we characterized the activity of LAT promoter fusion constructs in PC12 cells following treatment with nerve growth factor (NGF) and/or sodium butyrate (NaB), agents that affect expression of cell cycle-associated genes. Expression from the LAT promoter was induced 8-to 12-fold by either NGF or NaB alone and 40-to 60-fold when the two agents were added simultaneously. Fibroblast growth factor also induced expression from the LAT promoter but to a lesser extent than NGF. Treatment with factors such as epidermal growth factor, phorbol myristate acetate, cyclic AMP, or KCl had no significant effect on LAT promoter activity. Notably, promoter-reporter constructs containing immediate-early (ICP0 and ICP4), early (ICP8 and UL9), and late (UL10 and UL30) viral promoters were induced only two-to fourfold by NGF, suggesting that the LAT promoter may be unusual among herpes simplex virus genes in the magnitude of its response to this factor. To identify pathways leading to LAT activation in vitro, we characterized the response of the LAT promoter to NGF and/or NaB in PC12-derived cell lines containing mutations in specific signal transduction pathways. We found that activation of the LAT promoter requires Ras activation and that activation of the serine/threonine kinase, Raf, is sufficient to induce LAT expression. Together, these results indicate that the LAT promoter is regulated via the Ras/Raf signal transduction pathway in response to external factors such as NGF and NaB and that LAT expression may be regulated by NGF in latently infected neurons.
During natural infection, herpes simplex virus (HSV) replicates initially in epithelial cells of the ocular and oral-facial region. Newly synthesized virions enter the termini of neurons at the site of infection, and virus is transported intra-axonally to neuronal nuclei in sensory ganglia. Studies of viral gene expression during acute infection of ganglionic neurons in animal models suggest that the virus encounters three broad classes of intraneuronal environments: (i) neurons that are fully permissive for productive infection, in which the full cascade of viral gene expression proceeds and progeny virus is produced; (ii) neurons that are nonpermissive, such that viral gene expression is almost completely repressed, being restricted to the latency-associated transcripts (LATs), and (iii) neurons that are semipermissive, permitting limited viral gene expression concurrent with LAT expression (34, 35, 50, 52) . In reality, neurons that exhibit a spectrum of permissivities likely coexist simultaneously in a single ganglion. A correlation has been demonstrated between the level of viral gene expression and the expression of markers for specific types of neurons, suggesting that cellular factors are key determinants of permissivity (34, 35) . During the establishment of neuronal latency, viral gene expression is repressed and no viral proteins or infectious virus is detectable. Recently published evidence suggests, however, that in addition to the abundantly transcribed LATs, extremely low levels of several immediate-early and early viral transcripts are synthesized in latently infected neurons (29) .
The LATs are a series of viral RNAs encoded by the repeat sequences (TR L and IR L ) bounding the unique long region of the viral genome (Fig. 1A) . Two abundant transcripts of 2.0 and 1.5 kb have been described (reviewed in reference 19) . All LATs share a common 5Ј end, and the 2.0-and 1.5-kb species are transcribed antiparallel to, and overlap, the 3Ј third of DNA encoding the ICP0 transcript (Fig. 1B) . The 1.5-kb transcript is a spliced derivative of the 2.0-kb transcript. In addition to the abundant, small (major) LATs, in situ hybridization of latently infected ganglia suggests the existence of a larger, less abundant (minor) LAT of greater than 8 kb (38) . Because the smaller, more abundant LATs are localized to the nucleus, lack 5Ј caps, and are not polyadenylated, it has been suggested that they are not mRNAs but stable introns of the larger Ͼ8-kb LAT (18) .
A region of approximately 600 bp upstream of the 5Ј end of the small LATs is recognized as the LAT promoter (Fig. 1C) , as deletion of this promoter results in the absence of LAT expression during lytic and latent infection (17, 31) . The LAT promoter contains elements typical of an RNA polymerase II-dependent eukaryotic promoter, including a TATA box, and putative binding sites for several cellular transcription factors. It also contains a binding site for an adenovirus USF-like factor important for basal LAT expression in transient expression assays (62) . Transient expression assays have also been used to identify a region of the LAT promoter necessary for efficient expression in neuronal cell types, as well as two binding sites for members of the ATF/CREB family of transcriptional activators (3, 4, 28, 32, 63) . Elements within the 600-bp region between the recognized LAT promoter and the 5Ј end of the small LATs have also been reported to affect the efficiency of LAT synthesis (25, 41) .
LAT expression has long been considered to be a marker of HSV type 1 (HSV-1) latency in neuronal ganglia, such that the number of LAT-positive cells as detected by in situ hybridization has been thought to reflect the number of cells containing viral genomes. Recently, however, sensitive in situ PCR analysis has detected viral DNA in cells that do not contain detectable levels of LATs (37, 46) . While these observations may be due to differences in sensitivities of RNA and DNA PCR techniques, the results suggest that LAT expression in neurons may be specifically regulated during latency. In the absence of viral proteins, the regulation of LAT expression must be mediated by cellular factors.
What might these cellular regulatory factors be? A potential candidate is nerve growth factor (NGF). NGF is the charter member of a family of neuronal growth and survival factors, the neurotrophins (reviewed in reference 51). Neurotrophins regulate a variety of neuronal functions, including gene expression, and play an important role in the development and maintenance of neurons of both the peripheral and central nervous systems. The effects of neurotrophins are mediated through tyrosine kinase-containing receptors that stimulate cellular pathways which ultimately regulate levels of gene expression in target cells. NGF in particular supports the survival of neurons in sympathetic ganglia and some populations of sensory neurons in dorsal root and trigeminal ganglia. The neurally derived rat pheochromocytoma cell line PC12 has served as a system in which to study the effects of NGF on cellular signal transduction pathways and gene expression. In response to NGF, PC12 cells cease dividing, extend long processes, become electrically excitable, and otherwise assume the characteristics of sympathetic neurons (26) . The expression of NGF and several other neurotrophins is activated in response to neuronal injury (22) . Interestingly, HSV-1 establishes latent infections in sensory neurons which depend on NGF for their development and survival, and neuronal injury has long been recognized as a powerful stimulus of HSV-1 reactivation (13, 15) . These findings support the hypothesis that NGF might regulate HSV gene expression during establishment, maintenance, or reactivation of latency.
Sodium butyrate (NaB) has wide-ranging effects on cells in culture, including altering levels of cellular gene expression and inhibiting DNA replication and progression through the cell cycle. In PC12 cells, NaB activates genes encoding Fos, proenkephalin, and two transglutaminases (10, 11, 40) . The mechanism of NaB regulation of gene expression is unknown (6, 12, 30) . cis-acting sequences necessary for the response to NaB have been identified in several promoters, although the proteins that bind to these sites have not been identified (8, 21, 23, 24, 39, 55) . In addition to altering levels of cellular gene expression, NaB can affect levels of expression of viral genes both directly and indirectly. NaB activates transcription from the HIV and Moloney murine sarcoma virus long terminal repeats (LTRs) (7, 8, 55) . Moreover, it blocks papovavirus replication (48a), but increases the permissivity of neuroblastoma cells for HSV-1 infection and endothelial and epithelial cells for cytomegalovirus, and activates Epstein-Barr virus lytic gene expression in lymphoblastoid cells (2, 14, 33, 43, 54) . VOL. 70, 1996 LAT PROMOTER MUTANTS 7425
The identification of cellular regulatory proteins that can alter levels of HSV-1 gene expression in neurons is central to understanding the mechanism of establishment and reactivation from latency. As the only viral gene products synthesized at high levels during latency, the LATs are assumed to be important for the establishment, maintenance, and/or reactivation of latency. Because the LAT promoter is "on" during latency when most other viral promoters are "off," it is an ideal probe for assessing the transcriptional regulatory environment of HSV-1-infected neurons. Although previous studies have focused on LAT promoter activity in neuronal and nonneuronal cells, they have not addressed the question of whether LAT synthesis is regulated in response to extracellular signals in cells of neuronal origin. Because of their ability to alter levels of transcriptional regulatory factors and activate gene expression in neurally derived PC12 cells, we chose to study the effects of NGF and NaB on LAT promoter expression.
We found that either agent alone is able to activate LAT promoter activity in PC12 cells and that the combined effect of the two agents is synergistic. This activation is specific for NGF and NaB, as other agents capable of inducing cellular earlyresponse genes and mitogenesis failed to activate the LAT promoter. By using PC12 cell-derived mutant cell lines, LAT promoter activity was shown to be induced through activation of the signaling molecules, Ras and Raf. These studies demonstrate that LAT expression can be regulated by a soluble growth factor, NGF, through cellular phosphorylation-dependent events and suggest that NGF may regulate LAT expression in infected neurons in vivo.
MATERIALS AND METHODS
Cell culture. PC12 cells were the generous gift of John Wagner (Cornell University Medical College, New York, N.Y.). Cells were grown at 37ЊC in 10% CO 2 in Dulbecco's modified Eagle medium (DME; Gibco, Gaithersburg, Md.) supplemented with 10% fetal calf serum (Sigma Chemical Company, St. Louis, Mo.), 5% donor horse serum (JRH Biosciences, Lenexa, Kans.), 0.37% bicarbonate, 0.03% glutamine, penicillin (100 U/ml), and streptomycin (100 g/ml). PC12-derived cell lines M-M17-26 and Z-M17-5, expressing the dominant negative form of Ras (Asp-17 Ha-Ras), were the generous gift of Geoffrey Cooper (Dana-Farber Cancer Institute, Boston, Mass.) and were cultured as described above (53) . The oncogenic Raf-expressing cell line IC4-raf was the generous gift of Tom Roberts (Dana-Farber Cancer Institute) and was cultured as described above (59) . Every 3 to 4 days, all cells were fed or passaged by repeated pipetting with a bent Pasteur pipette. NGF, human recombinant basic fibroblast growth factor (bFGF), and receptor-grade epidermal growth factor (EGF) were purchased from Collaborative Biomedical Products (Bedford, Mass.). 8-(4-Chlorophenylthio)adenosine 3Ј:5Ј-cyclic AMP (cpt-cAMP), butyrate, and retinoic acid were purchased from Sigma.
Plasmid construction. (i) pLATCAT2079. Viral DNA sequences in all plasmids were derived from HSV-1 strain KOS. To generate a plasmid containing the LAT promoter driving expression of the chloramphenicol acetyltransferase (CAT) gene, a 2,371-bp BspEI-RsrII (Ϫ2079 to ϩ292) (New England Biolabs, Beverly, Mass.) fragment containing the LAT promoter ( Fig. 1) was cloned from the BamB fragment of KOS DNA. The ends of this fragment were filled in with Klenow fragment (New England Biolabs) and ligated to XbaI linkers (New England Biolabs). Following digestion with XbaI, the LAT promoter fragment was cloned upstream of the bacterial CAT gene in the XbaI site of plasmid pCAT-KB, a derivative of pCAT-Basic (Promega, Madison, Wis.) in which the EcoRI fragment containing the simian virus 40 splice site and early polyadenylation signal was replaced with an EcoRI fragment containing the simian virus 40 late polyadenylation signal without splicing signals. The structure of the resulting plasmid, pLATCAT2079, was confirmed by restriction enzyme digestion.
(ii) Viral promoter-CAT plasmids. Plasmids pWRICP0, pIE3CAT, pL9 CAT2.2, pMRICP8, pUL10CAT, pL42CAT, and LST-U-CAT containing the promoters of the viral genes ICP0, ICP4 (immediate-early), UL9, ICP8 (early), UL9, ICP8 (early), UL10, and UL30 (late) and the L/STs (long/short transcripts)-open reading frame P were constructed as described previously (44, 45, 61) . Plasmid pMSG-CAT, encoding the mouse mammary tumor virus (MMTV) LTR driving expression of the CAT gene, was purchased from Pharmacia Biotech (Piscataway, N.J.).
Transient expression assays. PC12 cells were transfected by using Lipofectin (Gibco BRL, Gaithersburg, Md.) lipid-mediated transfer. Cells were plated 1 day prior to transfection in 75-cm 2 tissue culture flasks (6 ϫ 10 6 and 1.2 ϫ 10 7 cells per flask). Lipofectin (48 l) was mixed with serum-free DME (3 ml) in 15-ml polystyrene tubes, and DNA (30 to 72 g) was mixed with serum-free DME in separate 15-ml polystyrene tubes. The suspensions containing Lipofectin and DNA were mixed and incubated at room temperature for 10 to 15 min. During incubation, serum-containing medium was removed from PC12 cells and cells were rinsed with serum-free medium. Following incubation, the Lipofectin-DNA-containing suspension (6 ml) was added to cells, which were then incubated for 3 to 5 h at 37ЊC. Following incubation, the suspension was removed, serum-containing DME was added back to cells, and the transfected cells were allowed to recover overnight. The following day, cells from independent transfections were pooled to control for transfection efficiency and plated in 60-mmdiameter dishes at a density of 10 6 cells per dish in medium containing inducing agents.
Cells were harvested at the indicated times posttransfection by scraping into Tris-buffered saline solution (150 mM NaCl, 10 mM Tris [pH 7.5]). Cells in suspension were pelleted by low-speed centrifugation, resuspended in 250 mM Tris, and frozen at Ϫ70ЊC for later assay of reporter enzyme (CAT) concentration.
CAT enzyme assay. Cell lysates for determination of CAT enzyme activity were prepared by three cycles of rapid freezing and thawing followed by incubation at 65ЊC for 10 min to reduce endogenous deacetylase activity and highspeed centrifugation to remove cell debris. CAT enzyme activity was assayed by the phase extraction method (48) . Briefly, crude cell lysates were incubated with butyryl coenzyme A (375 M) and [
14 C]chloramphenicol (0.1 Ci) in a reaction volume of 100 l for 60 min at 37ЊC. Following incubation, reaction mixtures were placed on ice and extracted with 500 l of 2:1 tetramethyl pentadecane (pristane)-xylenes to isolate butyrylated [
14 C]chloramphenicol; 350 l of the organic extraction mixture was removed for liquid scintillation counting. The volume of cell lysate added to each reaction was adjusted to keep the reaction linear with respect to enzyme activity per microliter of crude lysate per hour. The linear range of the assay was determined by measurement of CAT activity in a dilution series of crude extract. Values from CAT assays were not normalized to the concentration of protein in the lysate because treatment with NGF and NaB changes the size of individual cells as well as the rate at which PC12 cells divide. The transfected cells were pooled before plating into individual dishes; thus, each dish contained the same amount of plasmid DNA prior to treatment with the inducing agents. Equal volumes of lysate were used to generate the datum points within an experiment, and each datum point was derived from duplicate plates of cells.
RESULTS
The HSV-1 LAT promoter is activated by NGF and NaB. In attempting to identify neuronal factors that regulate HSV-1 gene expression (and LAT expression in particular), an important consideration was the choice of cells to be used for in vitro testing. After considering the use of other available cells which resemble peripheral system neurons, PC12 were chosen for the following reasons: (i) the use of primary cells is limited by the relatively small amount of material available for molecular biological and biochemical studies and by concerns about the heterogeneity of preparations of neuronal cells; (ii) primary neurons have limited passage potential and are difficult to transfect, making genetic studies impossible; (iii) PC12 cells are of neural lineage, are easily infected and transfected, and are available in sufficient quantities for biochemical studies; and (iv) activation of cellular gene expression and differentiation by NGF and NaB have been characterized in PC12 cells (11, 40, 49) .
To determine the effects of NGF and NaB on the LAT promoter, we transfected PC12 cell monolayers with a plasmid (pLATCAT2079) containing sequences from Ϫ2079 to ϩ292 of the LAT promoter driving expression of the CAT gene (Fig.  1) . To control for transfection efficiency, cells from independent transfections were pooled and then split into individual cultures. Each culture was mock induced or induced with NGF alone, NaB alone, or the two agents together. Normal medium and medium containing inducing agents was changed every 3 days.
LAT promoter-driven CAT activity on days 1 to 8 was significantly greater in induced cells than in uninduced cells (Fig.  2) . Treatment with either NGF alone or NaB alone resulted in a linear increase in CAT activity beginning 24 h after treatment and continuing through the end of the experiment. Maximum induction by either agent alone was ϳ10-fold, whereas addition of the two agents together resulted in synergistic activation of more than 40-fold after 6 days and 60-fold after 8 days of treatment. These experiments indicate that LAT promoter activity in PC12 cells can be activated by NGF or NaB. The synergy between NGF and NaB suggests that the two agents effect different rate-limiting steps in promoter activation. The kinetics of induction of this activation is similar to that observed following induction of cellular delayed-response genes.
Other recognized inducers of cellular gene expression fail to activate the HSV-1 LAT promoter in PC12 cells. To determine the relevance of LAT promoter induction by NGF and NaB, we examined whether agents other than NGF and NaB can activate the LAT promoter. PC12 cells transfected with the pLATCAT2079 construct were treated with agents known to activate several different cellular signal transduction pathways, and CAT enzyme activity was measured 1 and 6 days posttreatment.
As reported previously (32) , cAMP activated LAT promoter activity two-to threefold in the 6-day test period (Fig. 3) . By contrast, KCl (which activates calcium-dependent kinases), retinoic acid (which activates its own receptors), phorbol myristate acetate (PMA) (which activates protein kinase C), and EGF (which activates mitogenic signal transduction pathways) had no significant effect on LAT promoter activity in these experiments. Notably, EGF was mitogenic for PC12 cells, whereas treatment with cAMP or KCl was morphogenic, producing a flattened morphology and extension of short neuritic projections. These projections were much shorter than those produced in response to NGF, however. Although long-term treatment with PMA results in down regulation of protein kinase C, shorter treatments were similarly without effect on the LAT promoter (data not shown). In sum, the LAT promoter is activated in PC12 cells in response to NGF or NaB but not a variety of other extracellular signaling agents.
Effect of NGF and NaB on other HSV-1 promoters. Next we examined whether NGF and NaB might also have an effect on the promoters of viral genes expressed during productive infection. To address this question, we transfected PC12 cells with promoter-CAT constructs containing immediate-early (ICP0 and ICP4), early (ICP8 and UL9), or late (UL10 and UL30) promoters. In addition, we tested the promoter of the L/STs, which comprise a unique class of viral transcripts expressed only in the absence of ICP4 (60) . As a non-HSV control, we tested an MMTV LTR promoter-CAT construct.
The two immediate-early promoters, ICP4 and ICP0, were induced ϳ4-fold by NGF, whereas several early and late gene promoters were induced by only 2-to 3-fold (Fig. 4) . Collectively, these inductions were three-to sixfold less than NGF induction of the LAT promoter, suggesting that the LAT promoter may be unusual among HSV-1 promoters in the magnitude of its response to NGF.
In contrast to NGF, several viral promoters active during productive infection were more strongly induced by NaB. In particular, the promoters of the immediate-early genes ICP0 and ICP4 and the late genes UL30 (L42) and UL10 were activated eightfold or more. Treatment of the various HSV-1 promoters with both agents together resulted in additive (ICP8 and UL10), synergistic (ICP0, ICP4, and UL30), or only modest (UL9) activation. Neither NGF nor NaB had any significant effect on CAT expression from the L/ST or MMTV promoter.
These experiments demonstrate that in addition to the LAT promoter, expression of a number of HSV-1 genes is enhanced in the presence of cellular activators. It is noteworthy that among all of the non-LAT genes tested, the two immediateearly promoters (those of ICP0 and ICP4) were the most FIG. 2 . Activation of the LAT promoter by NGF and NaB. PC12 cells were transfected with plasmid pLATCAT2079 and incubated in medium containing NGF (100 ng/ml) (F), NaB (1.25 mM) (å), NGF (100 ng/ml) and NaB (1.25 mM) simultaneously (}), or neither inducer (s). Cells were harvested on days 1, 3, 6, and 8 after addition of inducers, and CAT enzyme activity was assayed. Fold inductions were calculated by dividing activity from treated cells by activity from untreated cells. Datum points are averages of the activities in two or three separately treated plates from one experiment. The experiment was repeated three times with essentially the same results. 
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LAT PROMOTER MUTANTS 7427 strongly induced by NGF, although this induction was less than half of that observed for the LAT promoter. bFGF activates the HSV-1 LAT promoter cooperatively with NGF or NaB. bFGF has effects similar to those of NGF in PC12 cells in that treatment results in differentiation and extension of neurites (27) . Induction of differentiation-specific gene expression occurs to a lesser extent in response to bFGF than to NGF, however (27) . To determine whether bFGF shares with NGF the ability to activate the LAT promoter, we treated pLATCAT2079-transfected PC12 cells with bFGF alone or in combination with NaB and/or NGF. After 6 days, bFGF induced the LAT promoter approximately 2-fold when used alone but 10-fold additively with NGF (Fig. 5) . This result is consistent with previous studies of NGF and bFGF gene activation in PC12 cells (27) . bFGF was also able to activate the LAT promoter additively with NaB; however, this activation was not as great as the synergistic activation by NGF and NaB. Treatment with bFGF, NGF, and NaB simultaneously failed to activate the LAT promoter to a level substantially higher than treatment with only NGF and NaB. This observation suggests that LAT promoter activation was saturated in the presence of all three inducers or that NGF, NaB, and bFGF share a common link within their signal transduction pathways. Thus, bFGF likely activates the LAT promoter through a mechanism similar to that used by NGF, albeit to a lesser extent.
NGF-and NaB-induced activation of the LAT promoter requires activation of Ras. Activation of gene expression by NGF occurs through well-characterized signal transduction pathways. Previous work has shown a pathway from the NGF receptor, TrkA, through the GTP-binding protein, Ras, and the serine/threonine kinase, Raf, to activation of downstream kinases leading ultimately to promoter activation (reviewed in reference 36) (Fig. 6 ). The genes induced by NGF can be classified according to the signaling molecules required for their activation (16) (Fig. 6 ). For example, induction of SCG10 requires activation of Ras but not Raf. In contrast, the lateresponse gene transin as well as the immediate-early genes VGF and zif/268 all require both Ras and Raf activation for their induction.
To identify signal transduction proteins involved in NGF and NaB induction of the LAT promoter, we used PC12 cell lines expressing mutant forms of the Ras and Raf proteins. The cell lines M-M17-26 and Z-M17-5 are PC12-derived cell lines stably transformed with the Ha-ras gene in which a point mutation in codon 17 results in substitution of asparagine for serine (53) . This mutant form of Ras preferentially binds GDP rather than GTP and acts as a dominant negative inhibitor of Ras function. NGF-dependent gene expression is greatly diminished in these cells, and they fail to differentiate functionally or morphologically in response to NGF (53) .
To determine the effect of the mutant Ras protein on NGFand NaB-mediated gene expression, we transfected M-M17-26 and Z-M17-5 cells with pLATCAT2079 and treated them with NGF, NaB, or both agents together for 6 days. The ability of either agent alone and of both agents together to activate the LAT promoter was markedly reduced in these two cell lines relative to PC12 cells (Fig. 7) . NGF activation was less than 3-fold in these cells, compared with ϳ10-fold in wild-type PC12 cells. NaB treatment similarly failed to activate the LAT promoter efficiently in these cells, and treatment with both agents together resulted in only ϳ3-to ϳ7-fold activation, compared with ϳ30-fold activation in wild-type PC12 cells. Slightly greater activation by the two agents was observed in Z-M17-5 cells than in M-M17-26. This increased activation correlates with the lower levels of inhibitory Asn-17 Ha-Ras detected in Z-M17-5 cells than in M-M17-26 cells (53) . As anticipated, neither cell type extended neurites in response to NGF treatment. The similarity of the response observed in these two independent cell lines suggests that the reduced activation observed is due to expression of the mutant Ha-ras gene and not other unspecified mutations. The reduced induction of the LAT promoter by NGF and NaB in M-M17-26 and Z-M17-5 cells suggests that Ras activation participates in LAT promoter induction by these two agents. Although the mechanism of NaB-dependent gene activation is unknown, these results imply that Ras participates in NaB induction of the LATs.
Activation of Raf is sufficient to activate the HSV-1 LAT promoter in PC12 cells. Having demonstrated that NGF-and NaB-dependent LAT promoter activation occurs downstream of Ras activation, we sought to determine whether activation of the Raf serine/threonine kinase was sufficient to induce this promoter. The PC12-derived cell line IC4-raf expresses an oncogenic activated form of c-Raf-1 under the control of the dexamethasone-inducible MMTV promoter (59) . Treatment of IC4-raf cells with dexamethasone induces expression of the activated mutant Raf, resulting in activation of NGF-dependent immediate-early and delayed-response genes as well as extension of long neurite-like processes.
PC12 and IC4-raf cells were transfected with plasmid pLAT-CAT2079 and treated with dexamethasone, NGF, or NaB alone or in combination. Treatment of PC12 cells with dexamethasone alone had no effect on LAT promoter expression (Fig. 8) . By contrast, when transfected IC4-raf cells were treated with dexamethasone to induce the activated raf oncogene, LAT promoter activity was induced more than 10-fold. As expected, treatment of IC4-raf cells with NGF or NaB also resulted in activation of LAT promoter activity. Treatment with both dexamethasone and either NGF or NaB resulted in combined activation of nearly 30-fold. The additivity of LAT promoter activation may be the result of activation of either endogenous Raf activity or of parallel signaling pathways which share downstream effectors in these cells. It is unlikely that LAT induction resulted from the combined effects of dexamethasone and Raf, as the activity produced by the NGFplus-dexamethasone control was not additive in PC12 cells. As expected, IC4-raf cells extended long neurites in response to dexamethasone induction of oncogenic Raf protein. These results indicate that activation of Raf is sufficient for activation of the LAT promoter in PC12 cells.
Collectively, the results of these experiments allow us to FIG. 7 . HSV-1 LAT promoter activation by NGF or NaB in PC12-derived cell lines containing dominant inhibitory Asp-17 Ha-Ras. PC12, Z-M17-5, or MM17-26 cells were transfected with plasmid pLATCAT2079 and treated with no inducer, NGF (100 ng/ml), NaB (1.25 mM), or NGF (100 ng/ml) and NaB (1.25 mM) simultaneously for 6 days. Fold induction was calculated by dividing the CAT activity from induced cells by the activity from uninduced cells. Each datum point is the average of the activities from duplicate plates in three separate experiments. Error bars represent the standard error of the mean. classify the LAT promoter within the model of signal transduction-dependent gene activation described above and indicate that the LAT gene belongs to the class of NGF-dependent genes which includes zif/268, transin, and VGF (Fig. 6) . These genes are all induced via activation of Ras and Raf signaling pathways. We wish to emphasize that although these experiments demonstrate that activation of Raf is sufficient for LAT activation, they do not address the question of necessity. Activation of alternative Ras-dependent pathways may be sufficient for LAT promoter activation.
DISCUSSION
Regulation of LAT promoter activity in neuronal cells. Several previous studies have focused on regulation of LAT expression in neuronal and nonneuronal cells, but none of these studies addressed the question of whether LAT expression is regulated in response to extracellular signaling molecules in neural cells either in vitro or in vivo. In this report, we describe activation of the LAT promoter in PC12 cells in response to NGF and NaB. This activation occurs with late kinetics, reaching a maximum at or after 8 days of treatment with either agent.
Previous efforts to demonstrate changes in LAT expression in vitro in response to cAMP, PMA, or NGF demonstrated less than a threefold induction with these agents (32) . However, these studies were performed after an 18-h NGF incubation and with a LAT promoter construct truncated at ϳ140 nucleotides, as opposed to ϳ2,100 nucleotides in the current study. The nearly threefold induction in LAT promoter activity in response to dibutyryl-cAMP observed in these studies was eliminated by mutation of the cAMP response element at position Ϫ40 (32) . Recent studies have demonstrated that mutation of this element in the HSV-1 genome does not effect the number of LAT-positive cells in mouse trigeminal ganglia (1, 42) . In the present study, we tested a LAT promoter construct bearing the same cAMP response element mutation for responsiveness to NGF or NaB and found that the mutation had no effect on promoter activation by these agents (data not shown).
The results of two recent studies indicate that the LATs may be expressed at different levels in genome-containing ganglionic neurons (37, 46) . Both of these studies used in situ PCR to compare levels of HSV-1 RNA and DNA in infected cells, and both found greater numbers of DNA-containing neurons than LAT-containing neurons in latently infected trigeminal ganglia. As the authors of both reports state, the failure to detect LATs in some DNA-containing neurons may be due to the greater sensitivity of the DNA detection technique than of the RNA detection technique, or it may reflect the absence of LAT expression in some latently infected neurons. It is not yet clear whether LAT expression in latently infected neurons is a function of neuronal cell type or the permissivity of the intracellular environment of a given neuron. The current study supports the idea that LAT expression can vary as a consequence of differences in the kinds and levels of cellular factors induced or activated by agents such as NGF.
Mechanism of induction by NGF and NaB. The mechanism of activation of cellular gene expression by NGF in PC12 cells has been relatively well characterized. NGF binding to the TrkA receptor tyrosine kinase activates Ras/Raf/MEK/ERK signaling pathways, resulting in changes in phosphorylation of transcription factors (reviewed in reference 36). These changes activate expression of immediate-early genes such as members of the fos and jun family as well as zif268, nur77, NF-B, and others. The products of these genes are regulatory proteins that activate a wide variety of so-called delayed-response genes at times ranging from several hours to several days following exposure to NGF.
The LAT promoter responds to NGF-induced changes in cellular factors beginning approximately 24 h after treatment and reaches a maximum after more than 6 days of treatment. In the accompanying report, we describe the identification of cis-acting elements within the LAT promoter that are required for activation by NGF and characterize alterations in nuclear protein complexes bound to these elements in response to NGF treatment (20) . The cis-acting elements identified are not similar to the binding sites of any known transcriptional activators. Thus, we believe that the LAT promoter is induced by NGF through a Ras/Raf signaling cascade, resulting in changes in the activity of novel upstream activators of transcription. We are currently testing this hypothesis.
Of interest was the observation that the immediate-early promoters of ICP0 and ICP4 were activated more efficiently than all other viral promoters tested except the LAT promoter. In recent studies of viral transcription in latently infected ganglia, low levels of ICP4 transcripts were detected (29) in addition to the LATs. It may well be that low levels of immediateearly transcripts are produced in latently infected ganglia in response to NGF. Confirmation of this hypothesis awaits further testing.
The mechanism by which NaB activates gene expression is not well understood. Despite early reports demonstrating that NaB inhibits deacetylation of histones, this activity has been shown to have little effect on gene expression (6, 12, 30) . More recent evidence indicates that NaB blocks late G 1 progression while not affecting expression of early cell cycle-related genes such as c-myc and c-jun (13a). Consistent with this observation, our studies demonstrate that full NaB-dependent activation of the LAT promoter requires activation of the GTP-binding protein, Ras. This requirement suggests that NaB must somehow activate early events in cellular signal transduction pathways near the cell surface. Because of the long delay between NaB treatment and activation of the LAT promoter, it is possible that NaB has effects in the nucleus that indirectly activate Ras-dependent signal transduction pathways.
The molecular basis for the synergistic activation of viral promoters by NGF and NaB is unknown, but a plausible explanation is that viral promoters are induced by factors dependent on the activation of immediate-early and/or early proteins in G 1 . NGF induces expression of immediate-early and early cellular genes early in G 1 , and NaB blocks expression of late but not early G 1 genes, leading to the further accumulation of cellular immediate-early and early proteins induced by NGF. Thus, the combined effects of both agents may produce cumulatively higher levels of cellular factors important for viral gene expression in G 1 than either agent alone.
The observed induction of the LAT promoter by NGF and/or NaB is not the result of nonspecific activation of gene expression or increased transfection efficiency for the following reasons. First, the inducing agents had different and reproducible effects on different viral promoters, with some promoters being induced to a greater or lesser extent by one or both of the agents. Notably, none of the non-LAT promoters was induced by NGF to the same extent as the LAT promoter construct, and the MMTV promoter construct was induced less than twofold by NGF and only slightly more than twofold by NaB or the two agents in combination. Second, as described in the accompanying report, induction by NGF and NaB is reduced more than 80% by 5Ј deletion of specific LAT promoter sequences, and the sequences required for NGF and NaB induction are different from the sequences required for basal pro-moter activity in PC12 cells. The fact that neither the ϳ8-kb MMTV promoter construct nor the ϳ4-kb LAT promoter construct in which sequences upstream of Ϫ81 were deleted was efficiently induced by NGF or NaB suggests that the size of the transfected plasmid is not an important determinant of inducibility. Finally, examination of levels of transfected pLATCAT2079 in transfected cells by slot blot analysis of nuclear DNA revealed no differences in the amounts of transfected plasmid taken up by cells treated with the various agents (data not shown).
Roles of Ras and Raf in LAT promoter activation. Using PC12 cell-derived mutant cell lines, we have demonstrated that Ras activation is required for maximum LAT promoter induction by NGF or NaB and that activation of Raf is sufficient for promoter activation. The demonstration that activation of Ras and Raf in PC12 cells leads to LAT promoter activation raises the question, Under what circumstances might Ras and Raf activation in vivo lead to LAT promoter induction? Importantly, treatment of PC12 cells with EGF leads to Ras and Raf activation but not to LAT promoter activation. Likewise, EGF treatment results in a mitogenic response in these cells, while NGF treatment results in differentiation and growth inhibition (26) . Recent studies of the effects of these agents on activation of Ras, Raf, and other downstream molecules suggest that the duration of activation by these effectors may determine the specificity of their effects and that only strong stimuli result in activation of the full program of downstream gene activation (reviewed in reference 36). If the results obtained for PC12 cells hold true for neurons in vivo, our findings suggest that the LAT promoter may not be sensitive to the many different signals that activate immediate-early genes such as c-fos but may react to stronger signals such as those elicited by neurotrophins. Indeed, the survival-promoting effects of NGF and brain-derived neurotrophic factor on sensory neurons are blocked by anti-p21 ras antibodies, demonstrating that Ras activation is part of the neuronal response to these factors (9) .
Role of LAT promoter induction in the HSV life cycle. An important question that remains to be answered is whether the LAT promoter is induced in response to increases in ganglionic levels of NGF in vivo. If this proves to be the case, what might be the effect of this induction on the HSV-1 life cycle? Although recent evidence indicates that bovine herpesvirus 1 LATs encode an inhibitor of cyclin (47a), no evidence indicating that the HSV LATs even encode a protein has been presented. Studies of HSV-1 mutants defective in LAT expression have suggested that the LATs are required for efficient reactivation of virus from latency in vivo. On the other hand, some reports have suggested that the observed impairment in reactivation may, in fact, be the result of inefficient establishment of latency, leaving the actual role of the LATs unclear (47) . At the time of their discovery, it was noted that the LATs were transcribed antiparallel to the transcript of the potent HSV transactivator, ICP0. This finding led to speculation that the LATs might act through an antisense mechanism to establish and maintain HSV-1 latency (18) . This model fell from favor when LAT-null mutant viruses were observed to be impaired primarily in the ability to reactive. Nonetheless, a possible role for the LATs in efficient establishment of latency cannot be discounted. We are currently engaged in experiments to determine whether NGF-induced LAT expression modulates HSV-1 infection in trigeminal ganglia through antisense inhibition of the potent transactivator, ICP0. Such inhibition could conceivably reduce viral gene expression, virus production, and cell death during acute infection, resulting in greater numbers of viable, latently infected neurons. Thus, in response to reactivation signals, expression of NGF and other neurotrophins may serve to prevent reactivation through induction of the LATs. While investigations of this and other models of interactions between LATs, neurotrophins, and latent HSV-1 are in early and highly speculative stages, there can be little doubt that NGF and other neurotrophins which play vital roles in the function and survival of fully differentiated neurons must also have an effect on the latent virus within these cells.
